Stock Taper
OPPORTUNITY RADAR
SCREENER
COMPARE ANY 2 STOCKS
Pricing
Log In
SIGN UP
EARNINGS CALL ARCHIVE
1 CALL ON FILE
CNSP
— CNS Pharmaceuticals, Inc.
NASDAQ
FULL STOCK PAGE →
Q4 2019 Earnings Call Summary
MAR 12, 2020
REVENUE
$0
EPS
$28.32
+4820.0%
FREE CASH FLOW
-$2.5M
-557.5%
No summary has been written for this call yet.
← NEWER CALL
CALL 1 OF 1
OLDER CALL →